Longwood Biopharmaceuticals initiates clinical phase II study of LW402, a next-generation JAK1 inhibitor Longwood Biopharmaceuticals initiates clinical phase II study of LW402, a next-generation JAK1 inhibitor Recently, Longwood Biopharmaceuticals announced the initiation of a Phase II clinical study of ... Company News Mar 30, 2023
LongwoodPharmaceuticals Deeply Committed to the Pharmaceutical Industry, Contributing to the Health of China 時間：2021年08月02日 14:31 欄目：廣特播報 作者：廣通社 Science and technology self-reliance and self-improvement is the strategic support of national development, adhere to scientific and technological innovation is dri... Company News Mar 30, 2023